Longevity Industry Analytics

13/04/2026

𝐆𝐮𝐥𝐟 𝐍𝐞𝐰𝐬 𝐏𝐮𝐛𝐥𝐢𝐬𝐡𝐞𝐬 𝐂𝐨𝐦𝐦𝐞𝐧𝐭𝐚𝐫𝐲 𝐛𝐲 𝐃𝐦𝐢𝐭𝐫𝐲 𝐊𝐚𝐦𝐢𝐧𝐬𝐤𝐢𝐲 𝐨𝐧 𝐖𝐚𝐫 𝐀𝐧𝐱𝐢𝐞𝐭𝐲 𝐚𝐧𝐝 𝐋𝐨𝐧𝐠𝐞𝐯𝐢𝐭𝐲 𝐇𝐞𝐚𝐥𝐭𝐡

An opinion article authored by Dmitry Kaminskiy, General Partner at Deep Knowledge Group, has been published by Gulf News, examining the concept of “war anxiety” through the lens of longevity medicine.

The article advances the argument that prolonged exposure to conflict-related stress—particularly through continuous digital media consumption—constitutes not only a psychological burden but also a significant biological risk factor, contributing to accelerated ageing and increased susceptibility to chronic disease.

Kaminskiy outlines a structured framework of behavioural interventions aimed at mitigating these effects, including the regulation of information intake, the establishment of daily routines, the prioritisation of social connectedness, and the integration of physical activity. The analysis further emphasises the importance of emotional regulation and timely access to professional support where necessary.

From a strategic perspective, the commentary positions stress management as a core component of preventive health and longevity strategy, highlighting the growing relevance of resilience-building practices in environments characterised by sustained geopolitical uncertainty.

Read full article here:

Explore how longevity medicine can help manage war anxiety, reduce chronic stress and protect long-term mental and physical health in times of global conflict.

11/03/2026

𝐀𝐫𝐚𝐛 𝐍𝐞𝐰𝐬: 𝐓𝐡𝐞 𝐂𝐚𝐬𝐞 𝐟𝐨𝐫 𝐋𝐨𝐧𝐠𝐞𝐯𝐢𝐭𝐲 𝐈𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭 𝐢𝐧 𝐭𝐡𝐞 𝐆𝐮𝐥𝐟

Arab News has published a new opinion article by Dmitry Kaminskiy, General Partner of Deep Knowledge Group, examining how targeted investment in longevity-focused healthcare could significantly improve life expectancy across GCC countries.

The article highlights the region’s unique position to advance longevity science and healthcare innovation, given its access to capital, rapidly modernizing healthcare infrastructure, and strong government-led strategic initiatives. Kaminskiy outlines how allocating 1–2% of GDP toward longevity-oriented healthcare systems — including preventive medicine, advanced diagnostics, and emerging health technologies — could increase life expectancy in the Gulf by 2–4 years over the next two decades.

The article also emphasizes the importance of integrating AI-driven diagnostics, precision medicine, preventive healthcare programs, and age-related technologies to improve both lifespan and healthspan. In addition to public health benefits, the analysis highlights the broader economic impact of longevity investment, noting that healthier and longer-living populations can contribute to higher productivity, extended workforce participation, and more resilient healthcare systems.

https://www.arabnews.com/node/2635412

09/03/2026

𝐀𝐫𝐚𝐛 𝐍𝐞𝐰𝐬 𝐏𝐮𝐛𝐥𝐢𝐬𝐡𝐞𝐬 𝐃𝐦𝐢𝐭𝐫𝐲 𝐊𝐚𝐦𝐢𝐧𝐬𝐤𝐢𝐲 𝐂𝐨𝐦𝐦𝐞𝐧𝐭𝐚𝐫𝐲 𝐨𝐧 𝐋𝐨𝐧𝐠𝐞𝐯𝐢𝐭𝐲 𝐈𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭 𝐢𝐧 𝐭𝐡𝐞 𝐆𝐮𝐥𝐟

Arab News published an opinion article by Dmitry Kaminskiy, General Partner of Deep Knowledge Group, exploring how strategic investment in longevity-focused healthcare could increase life expectancy across GCC countries.

The article outlines how allocating 1–2% of GDP to longevity-oriented healthcare systems — including preventive care, advanced medical technologies, and healthier living environments — could raise life expectancy in the region by 2–4 years over the next two decades.

The commentary highlights Saudi Arabia and the UAE as well positioned to lead this development due to their expanding healthcare infrastructure and sustained investment in medical innovation. Saudi Arabia’s healthcare transformation under Vision 2030, alongside the UAE’s focus on biotechnology, regenerative medicine, and advanced medical research, is presented as a strong foundation for scaling longevity-focused initiatives.

The article concludes that sustained investment in longevity can generate both public health and economic benefits, supporting healthier populations, longer workforce participation, and more resilient healthcare systems across the Gulf.

With their rapidly advancing economies, young and ambitious populations, and strategic access to both capital and cutting-edge technologies, GCC nations such as Saudi Arabia, the UAE and others have the potential to dramatically increase life expectancy through smart investments in longevity-focused...

23/01/2026

Deep Knowledge Group featured in Arab News on longevity as an economic strategy

We are pleased to see Arab News publish an in-depth opinion piece by Dmitry Kaminskiy, General Partner at Deep Knowledge Group, highlighting longevity not as a healthcare cost, but as a macroeconomic growth engine for the GCC and beyond.

The article outlines how extending healthy life expectancy by just 2–4 years could generate a $70–$100 billion Longevity Dividend for GCC economies by 2030 — driven by higher productivity, longer workforce participation, and reduced chronic disease burden.

Key themes explored include:

- Longevity as a strategic economic pillar, not merely a public health objective

- The role of AI health platforms, smart hospitals, and preventive medicine

- GCC-specific advantages, including high per-capita GDP, demographic structure, and rapid healthtech adoption

- Investment opportunities across biotechnology, digital therapeutics, AI health analytics, and longevity-focused industries

At Deep Knowledge Group, we have long argued that longevity industrialization represents one of the most powerful — yet underleveraged — drivers of sustainable economic growth. Seeing this framework discussed in a leading international publication reinforces the urgency for governments, investors, and institutions to treat longevity as a core component of national development strategies.

📖 Read the full article in Arab News:
https://arab.news/pperm

The growing focus on longevity industrialization in the Gulf Cooperation Council has the potential to significantly boost regional economies. By integrating cutting-edge healthcare systems, developing smart cities, and supporting increasing life expectancies, longevity could add an estimated $70–$...

19/12/2025

𝐃𝐞𝐞𝐩 𝐊𝐧𝐨𝐰𝐥𝐞𝐝𝐠𝐞 𝐆𝐫𝐨𝐮𝐩 𝐢𝐧 𝐅𝐨𝐜𝐮𝐬 | 𝐓𝐡𝐨𝐮𝐠𝐡𝐭 𝐋𝐞𝐚𝐝𝐞𝐫𝐬𝐡𝐢𝐩 𝐨𝐧 𝐋𝐨𝐧𝐠𝐞𝐯𝐢𝐭𝐲 & 𝐓𝐢𝐦𝐞 𝐄𝐜𝐨𝐧𝐨𝐦𝐢𝐜𝐬

Deep Knowledge Group is pleased to be featured in a new expert commentary on “Investing in the Age of Biological Reversibility,” authored by Dmitry Kaminskiy, General Partner of Deep Knowledge Group.

The piece explores how the MENA region is uniquely positioned to lead the global longevity transition, reframing ageing not as a cost center, but as a strategic, investable variable within modern financial and policy frameworks. Central to this analysis is the concept of time arbitrage — leveraging the widening gap between chronological age and achievable healthspan as a source of long-term economic value.

As longevity science, AI, and financial engineering converge, TimeTech is emerging as a defining paradigm of the 21st-century economy. The MENA region has the capital, governance ambition, and innovation capacity to lead this shift globally.

Deep Knowledge Group continues to work at the intersection of longevity, frontier technologies, and strategic capital, supporting governments, investors, and institutions in repricing time as humanity’s most valuable asset.

longevity infrastructure emerging as a new asset class in the region

15/12/2025

We are pleased to be featured in Intelligent CIO Middle East’s recent analysis, “Why the GCC must take the lead in the longevity revolution.”

The article highlights insights from Dmitry Kaminskiy, General Partner at Deep Knowledge Group, emphasizing the GCC’s unique opportunity to lead the global longevity economy through strategic investment in longevity science, preventive healthcare, biotechnology, and AI-driven innovation.

As longevity increasingly becomes a pillar of national competitiveness and economic resilience, the GCC’s visionary leadership, strong capital base, and commitment to future-oriented policy position the region to move from being a consumer of longevity technologies to a global producer and exporter of longevity solutions.

At Deep Knowledge Group, we remain committed to advancing longevity as a core component of economic strategy, technological leadership, and societal progress across the Middle East and globally.

Read more: https://www.intelligentcio.com/me/2025/12/12/why-the-gcc-must-take-the-lead-in-the-longevity-revolution/

Why the GCC must take the lead in the longevity revolution Bill Tanner | 12 December, 2025 Dmitry Kaminskiy, General Partner, Deep Knowledge Group, says the Gulf Cooperation Council has a unique opportunity to position itself at the forefront of the global longevity revolution by investing in scie...

16/06/2025

Switzerland Longevity Platform is Now Live
Switzerland’s health innovation ecosystem is now mapped and open to the public.
The platform unifies companies, investors, hubs, and patents under one interactive landscape:
• 570+ Longevity companies
• 1,150 active investors
• 175 innovation hubs across Geneva, Lausanne, Zürich
• Linked to 5,300+ organisations and clinical frameworks
This is your open-access gateway to one of Europe’s top longevity ecosystems.
🔗 https://eu1.hubs.ly/H0l0Z2w0

16/06/2025

Explore the UAE’s HealthTech Ecosystem Like Never Before
🔎 Explore the UAE’s HealthTech Ecosystem Like Never Before
We’re excited to introduce the UAE HealthTech Platform, an open-access initiative by https://eu1.hubs.ly/H0l0Wd50 designed to map, structure, and elevate the region’s innovation landscape.
The platform brings together verified data on companies, investors, R&D hubs, and intellectual property — all in a single, easy-to-navigate interface.
Whether you’re a startup, policymaker, academic, or investor, this tool offers valuable insights and direct ways to contribute.
🔍 What You’ll Find:
• 695+ HealthTech companies across the UAE
• 295 investors, including major VCs
• 70+ innovation hubs, accelerators & institutions
• 1,030+ patents in diagnostics, biotech & digital health
• Public, real-time and structured data
• No cost. No login. Open to all
📍 Dive into the platform:
https://eu1.hubs.ly/H0l0T100

15/06/2025

🔎 The UAE HealthTech Platform is Now Live
We are proud to unveil the UAE HealthTech Platform, developed by https://eu1.hubs.ly/H0k_rx30 as part of a global initiative to map and empower health innovation ecosystems.
This open-access tool offers a structured, data-verified view of the UAE’s HealthTech landscape — bringing together companies, investors, research hubs and IP assets in one unified interface.
From early-stage startups to national R&D clusters, the platform enables users to explore key players, access ecosystem analytics, and contribute directly to a more transparent and collaborative future for health and longevity.
🔍 Key Features:
• 695+ mapped HealthTech companies
• 295 active investors & VCs
• 70+ innovation hubs and accelerators
• 1,030+ patents
• Structured, real-time data
• Free and open to all stakeholders
📍 Explore the platform today:
https://eu1.hubs.ly/H0k_rpH0

14/06/2025

🧠 Mapping the Minds Behind UAE HealthTech
Who’s leading the transformation of biotech, AI diagnostics, and digital health in the UAE?
This interactive mind map showcases the region’s top HealthTech visionaries — and how their work connects across research, innovation, and impact.
It’s not just a list. It’s a live, visualized network of leadership and collaboration.
📍Explore the platform:
https://eu1.hubs.ly/H0k_vCf0
🧭 Verify your presence on the ecosystem map and ensure your work is accurately represented:
https://eu1.hubs.ly/H0k_v5T0

13/06/2025

🔎 The United Kingdom’s Longevity Sector - Now Mapped and Open for Discovery
https://eu1.hubs.ly/H0k_fyJ0 proudly presents the UK Longevity Platform, offering open-access, data-verified insights into the region’s longevity ecosystem.
From London to Manchester, this interactive platform brings together thousands of companies, investors, hubs, and clinical research frameworks under one structured view.
🔍 Key Figures:
• 13,500+ longevity-focused companies
• 6,900+ active investors
• 800+ innovation hubs in London, Cambridge, Oxford, Manchester
• Linked to 13,500+ organisations, national R&D frameworks, and global clinical trials
📍 Explore more:
https://eu1.hubs.ly/H0k_b510